Unknown

Dataset Information

0

FibronectinEDA promotes chronic cutaneous fibrosis through Toll-like receptor signaling.


ABSTRACT: Scleroderma is a progressive autoimmune disease affecting multiple organs. Fibrosis, the hallmark of scleroderma, represents transformation of self-limited wound healing into a deregulated self-sustaining process. The factors responsible for maintaining persistent fibroblast activation in scleroderma and other conditions with chronic fibrosis are not well understood. Toll-like receptor 4 (TLR4) and its damage-associated endogenous ligands are implicated in immune and fibrotic responses. We now show that fibronectin extra domain A (Fn(EDA)) is an endogenous TLR4 ligand markedly elevated in the circulation and lesional skin biopsies from patients with scleroderma, as well as in mice with experimentally induced cutaneous fibrosis. Synthesis of Fn(EDA) was preferentially stimulated by transforming growth factor-? in normal fibroblasts and was constitutively up-regulated in scleroderma fibroblasts. Exogenous Fn(EDA) was a potent stimulus for collagen production, myofibroblast differentiation, and wound healing in vitro and increased the mechanical stiffness of human organotypic skin equivalents. Each of these profibrotic Fn(EDA) responses was abrogated by genetic, RNA interference, or pharmacological disruption of TLR4 signaling. Moreover, either genetic loss of Fn(EDA) or TLR4 blockade using a small molecule mitigated experimentally induced cutaneous fibrosis in mice. These observations implicate the Fn(EDA)-TLR4 axis in cutaneous fibrosis and suggest a paradigm in which aberrant Fn(EDA) accumulation in the fibrotic milieu drives sustained fibroblast activation via TLR4. This model explains how a damage-associated endogenous TLR4 ligand might contribute to converting self-limited tissue repair responses into intractable fibrogenesis in chronic conditions such as scleroderma. Disrupting sustained TLR4 signaling therefore represents a potential strategy for the treatment of fibrosis in scleroderma.

SUBMITTER: Bhattacharyya S 

PROVIDER: S-EPMC4414050 | biostudies-other | 2014 Apr

REPOSITORIES: biostudies-other

altmetric image

Publications

FibronectinEDA promotes chronic cutaneous fibrosis through Toll-like receptor signaling.

Bhattacharyya Swati S   Tamaki Zenshiro Z   Wang Wenxia W   Hinchcliff Monique M   Hoover Paul P   Getsios Spiro S   White Eric S ES   Varga John J  

Science translational medicine 20140401 232


Scleroderma is a progressive autoimmune disease affecting multiple organs. Fibrosis, the hallmark of scleroderma, represents transformation of self-limited wound healing into a deregulated self-sustaining process. The factors responsible for maintaining persistent fibroblast activation in scleroderma and other conditions with chronic fibrosis are not well understood. Toll-like receptor 4 (TLR4) and its damage-associated endogenous ligands are implicated in immune and fibrotic responses. We now s  ...[more]

Similar Datasets

| S-EPMC3420161 | biostudies-other
2023-09-19 | GSE233595 | GEO
| S-EPMC3674667 | biostudies-literature
| S-EPMC3837995 | biostudies-literature
| S-EPMC3081345 | biostudies-literature
| S-EPMC7395242 | biostudies-literature
| S-EPMC6745032 | biostudies-literature
| S-EPMC4085166 | biostudies-other
| S-EPMC2994611 | biostudies-literature
| S-EPMC5526579 | biostudies-other